title: Emerging targets in osteoporosis disease modification.
authors.affiliation: Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, USA. johallen@amgen.com
authors.forename: John G
authors.initials: JG
authors.lastname: Allen
authors.forename: Christopher
authors.initials: C
authors.lastname: Fotsch
authors.forename: Philip
authors.initials: P
authors.lastname: Babij
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D010024:Osteoporosis / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism* / Q000503:physiopathology
chemical_list: D015415:Biomarkers